7 8b - Robuta Search

https://www.biospace.com/deals/gilead-doubles-down-on-car-t-with-7-8b-arcellx-acquisition Gilead Doubles Down on CAR T With $7.8B Arcellx Acquisition - BioSpace Feb 23, 2026 - The centerpiece of the takeover is anito-cel, a CAR T therapy under development for relapsed or refractory multiple myeloma. An FDA decision on the therapy is... 7 8b gilead doubles car arcellx https://www.theaireport.ai/newsletter/7-8b-to-52b-ai-agents-are-here ⚡ $7.8B to $52B, AI Agents Are Here | AI Tool Report Inside: Is your company ready? 7 8b ai agents tool report 52b https://www.genengnews.com/topics/translational-medicine/lilly-acquires-centessa-for-up-to-7-8b-biogen-buys-apellis-for-up-to-6-1b/ Lilly Acquires Centessa for Up to $7.8B; Biogen Buys Apellis for Up to $6.1B Mar 31, 2026 - Eli Lilly agrees to acquire sleep disorder drug developer Centessa Pharmaceuticals for approximately $7.8 billion, while Biogen agrees to purchase Apellis... 7 8b 6 1b lilly acquires centessa https://www.genengnews.com/topics/cancer/gilead-to-acquire-arcellx-for-7-8b-adding-anito-cel-to-cancer-pipeline/ Gilead to Acquire Arcellx for $7.8B, Adding Anito-Cel to Cancer Pipeline Feb 24, 2026 - Gilead Sciences has agreed to acquire Arcellx for $7.8 billion, the companies said today, in a deal intended to give the buyer full control of the buyout... 7 8b gilead acquire arcellx adding